Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

The fast-spreading virus can take multiple routes into developing human nerve cells.

Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

Explaining Chagas disease through the stories of patients in Bolivia.

Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.

Jennifer Allport-Anderson hunts for cardiac cures.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.